The use of biologics in the treatment of autoimmune liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of biologics in the treatment of autoimmune liver disease

Published:2020-02-26 Issue:4 Volume:29 Page:385-398
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Chang Christopher¹²^ORCID,Tanaka Atsushi³,Bowlus Christopher⁴,Gershwin M. Eric¹

Affiliation:

1. Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA

2. Division of Pediatric Immunology and Allergy, Joe DiMaggio Children’s Hospital, Hollywood, FL, USA

3. Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan

4. Division of Gastroenterology, University of California at Davis, Davis, CA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1733527

Reference149 articles.

1. De novo autoimmune hepatitis –is this different in adults compared to children?

2. Molecular mimicry and autoimmunity

3. Bystander activation and autoimmunity

4. Population-based epidemiology study of autoimmune hepatitis: A disease of older women?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study;Journal of Translational Medicine;2024-05-04

2. FcγRIIB expression increases during primary biliary cholangitis;Molecular Immunology;2023-10

3. Research gaps and opportunities in autoimmune hepatitis—Results of the international autoimmune hepatitis group research workshop 2022;Liver International;2023-04-10

4. Therapeutic Potential of The Low-dose IL-2 Through Targeting the Th17/Treg Axis in Primary Biliary Cholangitis Mice;2023-01-06

5. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China;World Journal of Gastroenterology;2022-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3